Paul Barnsley
Publications and Insights
- Publication: Taking STRIDES: The value of diagnostics against AMR
- Publication: Understanding the Full Value of Long-Acting Therapies: less is more?
- Publication: Analysing Global Immunisation Expenditure
- Publication: The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region
- Publication: 2023 OHE Annual Report to the Charity Commission
- Publication: Employer Costs from Respiratory Infections
- New: Applications open for MSc Fellowship Programme 2025
- Insight: R&D for new drugs to tackle AMR is a high-return investment for all EU member states
- Bulletin: Overcoming combination therapy challenges
- Publication: Unlocking the Value of Combination Therapies
- Publication: Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding
- Insight: Using Target Product Profiles (TPPs) to improve diagnostic testing for cancer
- Insight: NICE at 25: HTA Methods Guidelines – Evolution, not revolution
- Publication: How Have HTA Agencies Evolved Their Methods Over Time?
- Publication: Socio-Economic Value of Adult Immunisation Programmes
- Publication: Developing a Conceptual Framework of Healthcare System Pressure
- Insight: Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
- Insight: Around The World in HTAs: Türkiye – The bumpy road toward transformation
- Insight: Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
- Insight: Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
- New: Applications open for MSc and PhD Fellowship Programme 2024
- Publication: Capturing the Broader Value of Antibiotics
- Insight: OHE’s AMR consultation response
- Insight: Around The World in HTAs: The Slovak Republic – Valuing the Future
- Bulletin: The power of better diagnostics
- Insight: New Drugs to Tackle Antimicrobial Resistance: Breaking the European Deadlock: Part 1 – Defining Objectives
- Insight: Around The World in HTAs: The Netherlands – 5 Routes for New Tech
- Publication: A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance
- Publication: Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism
- Insight: Around The World in HTAs: Spain – Are We There Yet?
- Insight: Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
- Publication: The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
- Insight: Combination Therapies: A Step Forward to the Value Attribution Problem
- Publication: Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies
- Insight: The Economics of Antibiotics – Part 4: What Does the Antibiotics Market of the Future Look Like?
- Insight: The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics
- Insight: The Economics of Antibiotics – Part 2: Value Assessment within the NICE-NHS AMR Pilot
- Insight: The Economics of Antibiotics – Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment Model to Tackle Antimicrobial Resistance
- Insight: Improving the Measurement of Valued Output in Primary Care in England
- Insight: Let’s talk about (health) inequalities
- Insight: New NICE Manual for Health Technology Evaluations: A Critical Discussion on the Most Relevant Changes (or Lack Thereof)
- Publication: 2021 OHE Annual Report to the Charity Commission
- Publication: Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
- Insight: Would Waiving COVID-19 Vaccines Patents Save Lives?
- Insight: International Women’s Day: Why We #Choosetochallenge
- Insight: ‘HispaNICE’: the Creation of an ‘Independent Authority for the Evaluation of Health Practices and Policies’ Gathers Momentum
- Publication: Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations
- Publication: After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients
- Publication: The Value of Vaccines in Maintaining Health System Capacity in England
- Publication: Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making
- Publication: A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
- Publication: The Lower Drug Costs Now Act and Pharmaceutical Innovation
- Publication: Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective
- Publication: Exploring the Financial Sustainability of Gene Therapies
- Publication: Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?
- Publication: Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?
- Publication: Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology
- Publication: Opportunities to Increase Efficiency in Healthcare
- Publication: The BRAVE Initiative: The BRAVE Narrative for Broad Recognition of Value in Vaccines Engagement
- Publication: The Broader Value of Vaccines: The Return on Investment From a Governmental Perspective
- Publication: Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies
- Publication: International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making
- Publication: Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?
- Publication: Ethical and Economic Issues in the Appraisal of Medicines for Ultra-Rare Conditions
- Publication: Making Outcome-Based Payment a Reality in the NHS
- Publication: Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology
- Publication: Why Do Immigrants Report Lower Life Satisfaction?
- Publication: Transferability of HTA
- Publication: Age and Utilities: Issues for HTA
- Publication: Uncertainty and Risk in HTA Decision Making
- Publication: Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
- Publication: Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?
- Publication: A Study of the Relationship Between Health and Subjective Well-being in Parkinson’s Disease Patients